The clinical trials initiated in the United States and in Israel will evaluate safety, tolerability and efficacy of PrimeC, NeuroSense’s product for ALS patients.

* Required Field

Your E-Mail: *

Your Remark:

Friend's Name: *

Separate multiple entries with a comma. Maximum 5 entries.

Friend's E-Mail: *

Separate multiple entries with a comma. Maximum 5 entries.

Image Verification: *